REDBUD LABS Broadens MXR Chip Offering
MXR BLUE is designed for use in a wide range of applications, especially for system developers seeking to improve diagnostic sensitivity, shorten time-to-result, or simplify the consumable for a multiplexed genomic or proteomic test. With MXR BLUE, assay developers can now flood chambers directly with raw biofluids such as blood or urine, cell media, pure water, and other high-surface tension fluids. This new model rounds out the MXR offering, and follows the March launch of STRT, a cartridge-ready sample prep solution for microfluidic affinity sorting.
“We developed MXR BLUE based on customer demand” reports Dr. Jay Fisher, Vice President of R & D. “Researchers and systems developers alike have been seeking out the mixing advantages of MXR, but were restricted in their ability to utilize surfactants in their assays. Thanks to MXR BLUE’s hydrophilic characteristics this is no longer an issue. Developers can integrate the cartridge-ready chip into their protocols and immediately reap the rewards of MXR-enhanced mixing. With MXR BLUE, it’s now possible to work directly with non-diluted biological fluids like whole blood, urine, cerebral spinal fluid, saliva, synovial fluid, plasma, serum, etc.”
Redbud’s MXR chips are recognized for their rapid mixing capability in microfluidic volumes where reliance upon diffusion kinetics limits the performance of sample-to-answer assays. MXR chip models are assembled microfluidic components, well-suited for use with microarrays, reagent reconstitution and microfluidic cartridges. MXR BLUE comes in two standard chip assemblies. A wide range of made-to-order chips are also immediately available, thanks to Redbud’s rapid customization capabilities.
Redbud Labs, headquartered in Research Triangle Park, North Carolina, manufacturers breakthrough components for life science industry, intended to solve the industry’s ubiquitous microscale fluidic challenges. Redbud technologies have broad application across a variety of segments including basic research, drug discovery and development, biomanufacturing, diagnostics, sequencing and applied markets. Industry partners seek Redbud’s proprietary microchip technology, component design expertise and deep scientific know-how to advance their own next generation products. Rebudlabs.com
For further information contact:
VP Business Development
+1 919-537-9753 x97
400 Park Offices Dr.
RTP NC 27709
In The News
Redbud Labs announced NAxtract™, a fully automated sample preparation solution for low- to medium- throughput applications.